Low Dose Ketamine VR Analgesia During Burn Care Procedure (VRK)

National Institute of General Medical Sciences (NIGMS)

Status and phase

Completed

Phase 2

Conditions

Burn

Treatments

Behavioral: Virtual Reality

Study type

Interventional

Funder types

NIH

Identifiers

NCT01889537

43329-K

Details and patient eligibility

About

The purpose of the research is to see whether a low dose of ketamine, a medication used to reduce pain, enhances the effectiveness of a virtual reality video game, which is used as a form of distraction from pain during a painful burn care procedure.

Full description

This study is conducted in a hospital setting. It is a randomized controlled trial comparing the use of virtual reality distraction (VRD) and standard pain medications to the use of VRD, standard pain medications and a single low dose of ketamine as a means to reduce pain during a painful procedure in patients in the hospital.

Enrollment

3 patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Age greater than or equal to 18 years
Compliant and able to complete questionnaires
No history of psychiatric disorder
Not demonstrating delirium, psychosis or any form of Organic Brain Disorder
Able to communicate verbally
English-speaking
IV access already in place

Exclusion criteria

Age less than 18 years
Not capable of indicating pain intensity
Not capable of filling out study measures
Evidence of traumatic brain injury
History of psychiatric disorder
Demonstrating delirium, psychosis or any form of Organic Brain Disorder and associated memory problems
Unable to communicate orally
Receiving prophylaxis for alcohol or drug withdrawal
Developmental disability
Any face/head/neck injuries that interfere with the use of Virtual Reality equipment
Non-English Speaking
Extreme susceptibility to motion sickness
Seizure history
No IV access already in place